Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population
- PMID: 21927661
- PMCID: PMC3166673
- DOI: 10.5009/gnl.2011.5.3.321
Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population
Abstract
Background/aims: Helicobacter pylori causes numerous extragastric manifestations, including coronary heart disease. The coronary artery calcification (CAC) score, measured using computed tomography (CT) has been used as a screening test for coronary atherosclerosis. This study investigated the association between H. pylori seropositivity and CAC scores in a screening population.
Methods: Patients who underwent a health checkup between October 2003 and July 2007 and who did not have a history of ischemic heart disease were enrolled in the study. Subjects were screened with a multidetector CT scan to determine the CAC score and for anti-H. pylori antibody immunoglobulin G; traditional risks for coronary heart disease were evaluated using a structured questionnaire, anthropometric measurements, and laboratory tests.
Results: Of the 2,029 subjects enrolled (1,295 males), 1,214 (59.8%) subjects were H. pylori positive and 815 were H. pylori negative. There were no significant differences in the baseline characteristics of the seropositive and seronegative patients. When the CAC presence or absence scores were considered, multivariate analysis revealed that H. pylori seropositivity was statistically associated with the presence of CAC and that this association was stronger in the mild CAC score category.
Conclusions: H. pylori seropositive patients are at a higher risk for coronary atherosclerosis regardless of traditional cardiovascular risk factors. This association is particularly applicable for early coronary atherosclerosis.
Keywords: Coronary atherosclerosis; Helicobacter pylori; Screening; Seropositivity.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31. J Physiol Pharmacol. 2001. PMID: 11795863 Clinical Trial.
-
Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study.PLoS One. 2018 Mar 2;13(3):e0193646. doi: 10.1371/journal.pone.0193646. eCollection 2018. PLoS One. 2018. PMID: 29499055 Free PMC article.
-
Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.Int J Cardiol. 2007 Oct 18;121(3):229-38. doi: 10.1016/j.ijcard.2006.12.003. Epub 2007 Mar 26. Int J Cardiol. 2007. PMID: 17368586
-
Extracoronary Thoracic and Coronary Artery Calcifications on Chest CT for Lung Cancer Screening: Association with Established Cardiovascular Risk Factors - The "CT-Risk" Trial.Acad Radiol. 2015 Jul;22(7):880-9. doi: 10.1016/j.acra.2015.03.005. Epub 2015 May 7. Acad Radiol. 2015. PMID: 25957500 Review.
-
The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. doi: 10.3310/hta10390. Health Technol Assess. 2006. PMID: 17018228 Review.
Cited by
-
No detection of Helicobacter pylori in atherosclerotic plaques in end stage renal disease patients undergoing kidney transplantation.Indian J Nephrol. 2013 Jul;23(4):259-63. doi: 10.4103/0971-4065.114483. Indian J Nephrol. 2013. PMID: 23960340 Free PMC article.
-
Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks.Sci Rep. 2022 Oct 31;12(1):18284. doi: 10.1038/s41598-022-23191-z. Sci Rep. 2022. PMID: 36316430 Free PMC article.
-
Extraintestinal manifestations of Helicobacter pylori: a concise review.World J Gastroenterol. 2014 Sep 14;20(34):11950-61. doi: 10.3748/wjg.v20.i34.11950. World J Gastroenterol. 2014. PMID: 25232230 Free PMC article. Review.
-
Helicobacter pylori vs coronary heart disease - searching for connections.World J Cardiol. 2015 Apr 26;7(4):187-203. doi: 10.4330/wjc.v7.i4.187. World J Cardiol. 2015. PMID: 25914788 Free PMC article.
-
Helicobacter pylori and oral-gut microbiome: clinical implications.Infection. 2024 Apr;52(2):289-300. doi: 10.1007/s15010-023-02115-7. Epub 2023 Nov 2. Infection. 2024. PMID: 37917397 Free PMC article. Review.
References
-
- Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–1131. - PubMed
-
- Sipponen P, Hyvärinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl. 1993;196:3–6. - PubMed
-
- Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345:1525–1528. - PubMed
-
- Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter. 2008;13(Suppl 1):47–57. - PubMed
-
- Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007;101:203–209. - PubMed
LinkOut - more resources
Full Text Sources